Scibase AB
Research Scibase AB (SCIB) on Bullrun: market cap SEK 210.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCIB
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 210.64M
- Financial periodQ1 2026
- RevenueSEK 14.28M
- Net income-SEK 24.49M
- Free cash flow-SEK 26.57M
- Gross margin49.2%
Valuation Snapshot
latest market cap is SEK 210.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 40.46M | -SEK 98.23M | -SEK 84.90M | 64.6% | -0.23 | SEK 22.60M | n/a | SEK 6.66M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 210.64M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scibase AB's market cap?
Scibase AB's market capitalization is SEK 210.64M.
What does Scibase AB do?
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment.